What is the address of DR.ARJEN FEENSTRA, PEDIATER?

The registered office of DR.ARJEN FEENSTRA, PEDIATER is located at Romeinsesteenweg 523, 1020 Brussel.

Is DR.ARJEN FEENSTRA, PEDIATER still active?

Yes. According to the CBE (5 October 2026) DR.ARJEN FEENSTRA, PEDIATER is active, legal situation “Normale toestand”, started on 4 January 2008.

Is DR.ARJEN FEENSTRA, PEDIATER registered on Peppol?

No, DR.ARJEN FEENSTRA, PEDIATER is currently not registered on the Peppol network.

What is the enterprise number of DR.ARJEN FEENSTRA, PEDIATER?

The enterprise number of DR.ARJEN FEENSTRA, PEDIATER is BE0894634067.

When was DR.ARJEN FEENSTRA, PEDIATER founded?

DR.ARJEN FEENSTRA, PEDIATER was founded on 4 January 2008.

Who are the directors of DR.ARJEN FEENSTRA, PEDIATER?

According to the 2025 annual accounts, the directors of DR.ARJEN FEENSTRA, PEDIATER are: Arjen Feenstra.

Is DR.ARJEN FEENSTRA, PEDIATER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 4 January 2008; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR.ARJEN FEENSTRA, PEDIATER make in 2025?

DR.ARJEN FEENSTRA, PEDIATER recorded a loss after taxes of € 6,807 in financial year 2025.

What is the revenue of DR.ARJEN FEENSTRA, PEDIATER?

As a small company, DR.ARJEN FEENSTRA, PEDIATER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 18,048.

DR.ARJEN FEENSTRA, PEDIATER (Private Limited) - Brussel

Dossier DR.ARJEN FEENSTRA, PEDIATER, printed on 5 October 2026 from databakkes.be/en/0894634067/dr-arjen-feenstra-pediater. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2022.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR.ARJEN FEENSTRA, PEDIATER from Brussel, company number BE0894634067, closed financial year 2025 with a result of € -6,807 after tax. For that financial year DR.ARJEN FEENSTRA, PEDIATER recorded a gross margin of € 18,048 and equity of € 59,980. Compared with financial year 2024, the result moved from € 25,507 to € -6,807. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 59,980

▼ 48% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -6,807

▼ still € 25,507 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 40,341

▼ 42% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 29,980.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 45,070

▲ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,138

▲ 62% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,811

▲ 35% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 53,881 Gross margin 2022: € 53,881 First fiscal year in the series	€ 21,731 Gross margin 2023: € 21,731 ▼ 60% vs 2022 (€ 53,881) Unfavourable step	€ 76,208 Gross margin 2024: € 76,208 ▲ 251% vs 2023 (€ 21,731) Favourable step	€ 18,048 Gross margin 2025: € 18,048 ▼ 76% vs 2024 (€ 76,208) Unfavourable step	▼ 76%
Profit after taxes	€ 35,204 Profit after taxes 2022: € 35,204 First fiscal year in the series	€ -13,981 Profit after taxes 2023: € -13,981 ▼ € 49,185 vs 2022 (€ 35,204) Unfavourable step	€ 25,507 Profit after taxes 2024: € 25,507 ▲ € 39,488 vs 2023 (€ -13,981) Favourable step	€ -6,807 Profit after taxes 2025: € -6,807 ▼ € 32,314 vs 2024 (€ 25,507) Unfavourable step	▼ € 32,314
Equity	€ 141,260 Equity 2022: € 141,260 First fiscal year in the series	€ 127,279 Equity 2023: € 127,279 ▼ 10% vs 2022 (€ 141,260) Unfavourable step	€ 114,786 Equity 2024: € 114,786 ▼ 10% vs 2023 (€ 127,279) Unfavourable step	€ 59,980 Equity 2025: € 59,980 ▼ 48% vs 2024 (€ 114,786) Unfavourable step	▼ 48%
Total debts	€ 26,666 Total debts 2022: € 26,666 First fiscal year in the series	€ 18,624 Total debts 2023: € 18,624 ▼ 30% vs 2022 (€ 26,666) Favourable step	€ 9,252 Total debts 2024: € 9,252 ▼ 50% vs 2023 (€ 18,624) Favourable step	€ 54,071 Total debts 2025: € 54,071 ▲ € 44,819 vs 2024 (€ 9,252) Unfavourable step	▲ € 44,819
Cash	€ 146,136 Cash 2022: € 146,136 First fiscal year in the series	€ 75,617 Cash 2023: € 75,617 ▼ 48% vs 2022 (€ 146,136) Unfavourable step	€ 69,345 Cash 2024: € 69,345 ▼ 8% vs 2023 (€ 75,617) Unfavourable step	€ 40,341 Cash 2025: € 40,341 ▼ 42% vs 2024 (€ 69,345) Unfavourable step	▼ 42%
Retained profit	€ 111,260 Retained profit 2022: € 111,260 First fiscal year in the series	€ 97,279 Retained profit 2023: € 97,279 ▼ 13% vs 2022 (€ 111,260) Unfavourable step	€ 84,786 Retained profit 2024: € 84,786 ▼ 13% vs 2023 (€ 97,279) Unfavourable step	€ 29,980 Retained profit 2025: € 29,980 ▼ 65% vs 2024 (€ 84,786) Unfavourable step	▼ 65%
Dividend	€ 47,850 Dividend 2022: € 47,850 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 47,850) Unchanged	€ 38,000 Dividend 2024: € 38,000 Unchanged (€ 0) Unchanged	€ 48,000 Dividend 2025: € 48,000 ▲ 26% vs 2024 (€ 38,000) Unchanged	▲ 26%
Balance sheet total	€ 167,926 Balance sheet total 2022: € 167,926 First fiscal year in the series	€ 145,903 Balance sheet total 2023: € 145,903 ▼ 13% vs 2022 (€ 167,926) Unchanged	€ 124,039 Balance sheet total 2024: € 124,039 ▼ 15% vs 2023 (€ 145,903) Unchanged	€ 114,051 Balance sheet total 2025: € 114,051 ▼ 8% vs 2024 (€ 124,039) Unchanged	▼ 8%

Key figures of DR.ARJEN FEENSTRA, PEDIATER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR.ARJEN FEENSTRA, PEDIATER?

What happened at DR.ARJEN FEENSTRA, PEDIATER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: loss of € 6,807 (▼ € 32,314 vs 2024). filed late Source: NBB ↗
2023 Arjen Feenstra became a director. NBB
Jan 4, 2008 Start of the company according to the CBE. KBO

In short

From € 35,204 profit in 2022 to € 6,807 loss in 2025.

Paid € 24,460 in corporate taxes since 2022.

Best year ever: 2022, with € 35,204 profit.

Paid out € 133,850 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR.ARJEN FEENSTRA, PEDIATER? We notify you, reason included.

Follow DR.ARJEN FEENSTRA, PEDIATER

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Arjen Feenstra

DR.ARJEN FEENSTRA, PEDIATER

Behind DR.ARJEN FEENSTRA, PEDIATER is Arjen Feenstra.

See the full network in the app

Directors

According to the 2025 annual accounts

Arjen Feenstra

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Romeinsesteenweg 523

1020 Brussel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0894.634.067
VAT number: BE 0894.634.067
Registered office: Romeinsesteenweg 523, 1020 Brussel
Names & denominations: DR.ARJEN FEENSTRA, PEDIATER
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 4 January 2008
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗